The Food and Drug Administration (FDA) this week issued guidelines for drug manufacturers on developing opioid painkillers that are more difficult to abuse. The guidelines recommend the types of studies needed to prove drugs can deter abuse, The Wall Street Journal reports.
The FDA guidelines also make recommendations about how these studies should be performed and evaluated. They discuss what labeling claims may be approved based on the results of those studies, according to an agency news release.
The FDA said it hopes to encourage drug makers to develop opioids that are more difficult to crush, inject or snort to produce a more intense high. The agency noted even abuse-deterrent formulations are not “abuse-proof.”